[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
The World in Medicine
March 10, 1999

HIV Vaccine Trial in Africa

Author Affiliations

Not Available

Not Available

JAMA. 1999;281(10):889. doi:10.1001/jama.281.10.889

After 8 years of planning, the first clinical trial of an HIV vaccine in Africa has been launched in Uganda.

The trial is being conducted at the Joint Clinical Research Center in Kampala and at the Uganda Virus Research Institute in Entebbe. It will evaluate the safety and durability of immune response to a vaccine known as ALVAC vCP205, which is based on an attenuated canarypox virus. The vaccine contains only three HIV genes, rendering it incapable of causing HIV infection.